Sale or disposal
As filed · Strides Pharma Science Limited has informed the Exchange about Sale or disposal
M&AWatchNotablemateriality 72 out of 100
What happened
FactStrides Pharma Science Limited has informed the Exchange about Sale or disposal. Phiroze Jeejeebhoy Towers,. Transfer Agreement dated June 16, 2025, for divestment of its 100% shareholding in Strides CIS Limited,.
Why it matters
CapitSignal interpretationSelling a business converts an operating asset into cash; what the cash is then used for decides whether holders benefit.
What management said before
Prior statements by this company that CapitSignal has recorded changing.
Margins
RevisedEarlierQ1 FY27
EBITDA to PAT conversion at ~50%+
NowQ1 FY27
We expect gross margins to remain in the 58-60% range.
Change
FactTarget revision
Implication
CapitSignal interpretationThe stated figure moved 20.00%.confidence 60%
Watch next
Fact- Sale consideration
- Stated use of proceeds
- Revenue and profit leaving the group
- Aspire to focus on North America Business Revenue of ~$375m by FY28 despite current external headwinds (management committed by FY28)
- Continue to add new customers in Europe by leveraging strong commercial presence and robust supply chain (management committed by FY27)
Evidence
- Strides Pharma Science Limited has informed the Exchange about Sale or disposal(opens the original filing in a new tab)
- Earlier statement · Q1 FY27
- Latest statement · Q1 FY27
- Earlier statement · Q1 FY27
How CapitSignal classified this
- Reasoning:
- DIVESTMENT base 64; +5 quantified amount; +3 quantified percentage; matched on subject
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 75%